US EditionMounjaro or Wegovy? Scientists Compare Two Popular Obesity Drugs
Summary by thefad.pl
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
The first major comparative study of the most talked-about weight-loss drugs in recent years shows a clear leader. Tirzepatide (known as Mounjaro) proved more effective than semaglutide (Wegovy), although both drugs clearly support patients in the fight against obesity. Photo by Rachael Ren / Unsplash Efficacy of Mounjaro and Wegovy: New data from a clinical trial Researchers from the University of Glasgow and Weill Cornell Medicine in New York …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
